Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.1186/s40425-019-0565-5

Título: Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
Fecha de publicación: 8-abr-2019
Editorial: BMJ Publishing Group
Cita bibliográfica: Journal for ImmunoTherapy of Cancer, 2019, Vol. 7 (1) : 100
ISSN: Electronic: 2051-1426
Palabras clave: Conventional dendritic cells
cDC1
Cancer immunotherapy
Vaccination
Cell associated antigen
Cross presenting dentritic cells
Immunogenic cell death
Resumen: The manipulation of dendritic cells (DCs) for cancer vaccination has not reached its full potential, despite the revolution in cancer immunotherapy. DCs are fundamental for CD8+ T cell activation, which relies on cross-presentation of exogenous antigen on MHC-I and can be fostered by immunogenic cancer cell death. Translational and clinical research has focused on in vitro-generated monocyte-derived DCs, while the vaccination efficacy of natural conventional type 1 DCs (cDC1s), which are associated with improved anti-tumor immunity and specialize on antigen cross-presentation, remains unknown.
Autor/es principal/es: Wculek, Stefanie K.
Amores Iniesta, Joaquín
Conde Garrosa, Ruth
Kouili, Sofía C.
Melero, Ignacio
Sancho, David
Versión del editor: https://jitc.bmj.com/content/7/1/100.info
URI: http://hdl.handle.net/10201/145401
DOI: https://doi.org/10.1186/s40425-019-0565-5
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 16
Derechos: info:eu-repo/semantics/openAccess
Atribución 4.0 Internacional
Descripción: © The Author(s) 2019. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This document is the Published version of a Published Work that appeared in final form in Journal for ImmunoTherapy of Cancer. To access the final edited and published work see https://doi.org/10.1186/s40425-019-0565-5
Aparece en las colecciones:Informes o documentos de trabajo

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
2019 Wculek et al., JITC Immunotherapy cDC1.pdf1,7 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons